Albemarle (ALB) Projected to Post Earnings on Wednesday

Albemarle (NYSE:ALB - Get Free Report) is expected to be releasing its Q4 2024 earnings data after the market closes on Wednesday, February 12th. Analysts expect Albemarle to post earnings of ($0.60) per share and revenue of $1.34 billion for the quarter. Investors interested in listening to the company's conference call can do so using this link.

Albemarle (NYSE:ALB - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.49). Albemarle had a negative net margin of 28.80% and a positive return on equity of 1.67%. On average, analysts expect Albemarle to post $-2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Albemarle Price Performance

NYSE:ALB traded up $2.55 during midday trading on Thursday, hitting $79.15. 5,153,678 shares of the stock were exchanged, compared to its average volume of 2,481,890. The company has a market capitalization of $9.30 billion, a price-to-earnings ratio of -4.73, a P/E/G ratio of 3.43 and a beta of 1.59. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43. Albemarle has a one year low of $71.97 and a one year high of $143.19. The business has a 50-day moving average price of $89.56 and a two-hundred day moving average price of $92.39.

Analysts Set New Price Targets

Several brokerages recently weighed in on ALB. Evercore ISI cut Albemarle from an "outperform" rating to an "inline" rating in a research note on Wednesday, February 5th. BMO Capital Markets reduced their price objective on shares of Albemarle from $150.00 to $140.00 in a research report on Wednesday. UBS Group dropped their price target on Albemarle from $99.00 to $86.00 and set a "neutral" rating on the stock in a research note on Thursday. Truist Financial began coverage on shares of Albemarle in a report on Tuesday, January 28th. They set a "hold" rating and a $96.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Albemarle from $109.00 to $105.00 in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $113.14.

Insider Transactions at Albemarle

In related news, CEO J Kent Masters sold 2,525 shares of the company's stock in a transaction on Thursday, December 5th. The shares were sold at an average price of $101.12, for a total transaction of $255,328.00. Following the completion of the sale, the chief executive officer now directly owns 73,747 shares of the company's stock, valued at approximately $7,457,296.64. This represents a 3.31 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.38% of the stock is currently owned by corporate insiders.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.